Akari Therapeutics ADR
(AKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,718 | 4,016 | 3,328 | 0 | 0 |
| Marketable Securities | 142 | 142 | N/A | 0 | 0 |
| Receivables | 60 | 115 | N/A | 0 | 0 |
| Other current assets | 0 | 0 | 8 | 0 | 0 |
| TOTAL | $2,920 | $4,273 | $3,335 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 40 | 44 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 59 | 0 | 0 |
| TOTAL | $40 | $44 | $59 | $N/A | $N/A |
| Total Assets | $2,960 | $4,317 | $3,395 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 534 | 0 | 0 |
| Accounts payable and accrued liabilities | 960 | 910 | 595 | 0 | 0 |
| Accrued Expenses | N/A | N/A | 43 | 0 | 0 |
| TOTAL | $960 | $910 | $1,171 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,027 | 812 | 0 | 0 | 0 |
| TOTAL | $1,027 | $812 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,987 | $1,722 | $1,171 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 927 | 927 | 11,211 | 0 | 0 |
| Retained earnings | -34,178 | -32,507 | -11,479 | 0 | 0 |
| Other shareholders' equity | 0 | 0 | 46 | 0 | 0 |
| TOTAL | $973 | $2,595 | $2,223 | $0 | $0 |
| Total Liabilities And Equity | $2,960 | $4,317 | $3,395 | $0 | $0 |